Correlation Between Pfizer and ProShares

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and ProShares at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ProShares into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and ProShares SP Kensho, you can compare the effects of market volatilities on Pfizer and ProShares and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ProShares. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ProShares.

Diversification Opportunities for Pfizer and ProShares

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Pfizer and ProShares is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ProShares SP Kensho in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProShares SP Kensho and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ProShares. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProShares SP Kensho has no effect on the direction of Pfizer i.e., Pfizer and ProShares go up and down completely randomly.

Pair Corralation between Pfizer and ProShares

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.73 times more return on investment than ProShares. However, Pfizer Inc is 1.38 times less risky than ProShares. It trades about -0.04 of its potential returns per unit of risk. ProShares SP Kensho is currently generating about -0.12 per unit of risk. If you would invest  2,599  in Pfizer Inc on December 29, 2024 and sell it today you would lose (78.00) from holding Pfizer Inc or give up 3.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  ProShares SP Kensho

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
ProShares SP Kensho 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ProShares SP Kensho has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Etf's forward-looking signals remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the ETF investors.

Pfizer and ProShares Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and ProShares

The main advantage of trading using opposite Pfizer and ProShares positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ProShares can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProShares will offset losses from the drop in ProShares' long position.
The idea behind Pfizer Inc and ProShares SP Kensho pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities